Regression modelSocial EpidemiologyExposome / environmental epidemiologyModel

Exposome-Wide Association Study

Also known as: ExWAS, Environment-Wide Association Study, EWAS (environmental), Agnostic Exposure Scan

OriginatorChirag J. Patel, Jayanta Bhattacharya & Atul J. Butte (ExWAS); Christopher P. Wild (exposome concept)Year2010Sources2Related methods4

An exposome-wide association study (ExWAS), originally introduced as the Environment-Wide Association Study, applies the logic of the genome-wide association study to the environment. Where a GWAS scans hundreds of thousands of genetic variants for association with a trait, an ExWAS scans a broad panel of measured environmental exposures — nutrients, pollutants, chemical biomarkers, infectious markers, and behaviors — against a health outcome, fitting one adjusted regression per exposure and then rigorously controlling the multiple-testing burden across the whole set. The approach was demonstrated by Chirag Patel, Jayanta Bhattacharya, and Atul Butte in 2010 on type 2 diabetes using NHANES data, and it operationalizes Christopher Wild's 2005 concept of the 'exposome': the totality of environmental exposures complementing the genome. ExWAS turns environmental epidemiology from a one-exposure-at-a-time enterprise into a systematic, hypothesis-generating discovery scan.

Key highlights

  • Replaces one-exposure-at-a-time testing with a comprehensive, agnostic scan, reducing the selective-reporting and candidate-exposure bias of traditional environmental epidemiology.
  • Imports the rigorous multiple-testing and replication discipline of GWAS, so reported hits are calibrated against the breadth of the search.
  • Produces a comparable ranking of environmental correlates that prioritizes exposures for targeted causal follow-up.
  • Operationalizes the exposome concept, enabling environment-by-genome integration and systematic discovery across diverse exposure classes.

Intuition

This section is available to Pro members. Upgrade to Pro

How it works

This section is available to Pro members. Upgrade to Pro

When to use it

Use an ExWAS when you have a single health outcome and a broad battery of measured exposures on the same people, and you want an unbiased, systematic survey of which environmental factors are associated with the outcome rather than testing one favored candidate. It suits richly phenotyped resources — NHANES, large biobanks, and exposome cohorts — where many biomarkers and lifestyle variables are available, and it is ideal as a hypothesis-generating first pass that prioritizes exposures for later causal investigation. ExWAS is less appropriate when you already have a strong, specific causal hypothesis better served by a tailored design, when exposures are few, or when the goal is to estimate a causal effect rather than discover associations. Because exposures are correlated and time-varying and measurement error is common, ExWAS should be paired with replication and, ideally, downstream causal and sensitivity analysis before any finding is acted upon.

Strengths & limitations

Strengths
  • Replaces one-exposure-at-a-time testing with a comprehensive, agnostic scan, reducing the selective-reporting and candidate-exposure bias of traditional environmental epidemiology.
  • Imports the rigorous multiple-testing and replication discipline of GWAS, so reported hits are calibrated against the breadth of the search.
  • Produces a comparable ranking of environmental correlates that prioritizes exposures for targeted causal follow-up.
  • Operationalizes the exposome concept, enabling environment-by-genome integration and systematic discovery across diverse exposure classes.
Limitations
  • Yields associations, not causal effects; correlated and clustered exposures make confounding and reverse causation pervasive.
  • Many environmental exposures are time-varying and poorly captured by a single cross-sectional measurement, biasing estimates toward the null or in unpredictable directions.
  • Stringent correction for hundreds of tests sacrifices power, so true but modest associations can be missed.
  • Results depend heavily on which exposures happened to be measured and on covariate-adjustment choices, limiting completeness and comparability across studies.

Common pitfalls

This section is available to Pro members. Upgrade to Pro

Applications

This section is available to Pro members. Upgrade to Pro

Frequently asked

How is an ExWAS different from a GWAS?

The analytic logic is deliberately the same, but the variables differ. A GWAS scans fixed genetic variants for association with a trait; an ExWAS scans measured environmental exposures — biomarkers, chemicals, diet, and behaviors — against an outcome. Both fit one model per variable and apply stringent multiple-testing correction and replication. The crucial contrast is that the genome is fixed and measured almost without error, whereas the exposome is dynamic, correlated, and noisily measured, which makes confounding, reverse causation, and exposure measurement error far more serious concerns in ExWAS than in GWAS.

Does an ExWAS prove that an exposure causes disease?

No. ExWAS is a discovery and prioritization tool that produces associations under covariate adjustment, not causal estimates. Because environmental exposures cluster together and can proxy for unmeasured confounders or for reverse causation, a surviving, replicated hit should be read as a strong, prioritized hypothesis. Establishing causality requires follow-up: triangulation with other designs, sensitivity analyses such as E-values for unmeasured confounding, mechanistic evidence, or instrumental approaches. ExWAS narrows the field of candidate exposures so that scarce causal-inference effort is spent on the most promising leads.

How does ExWAS handle the multiple-testing problem?

By borrowing the GWAS discipline. Because the scan runs one test per exposure across a large panel, the analysis pre-specifies a stringent error-control rule — typically a Bonferroni threshold of alpha divided by the number of exposures, or a false-discovery-rate procedure that bounds the expected fraction of false positives among the hits. Only associations passing this threshold are carried to replication in an independent sample. This two-stage filter is what makes the breadth of the search statistically honest and distinguishes ExWAS from simply running hundreds of separate tests and reporting whatever reaches nominal significance.

Sources

  1. 1.
    Patel, C. J., Bhattacharya, J., & Butte, A. J. (2010). An Environment-Wide Association Study (EWAS) on Type 2 Diabetes Mellitus. PLoS ONE, 5(5), e10746.
  2. 2.
    Wild, C. P. (2005). Complementing the genome with an 'exposome': the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiology, Biomarkers & Prevention, 14(8), 1847-1850.

You have read it. What now?

Cite this page

ScholarGate. (2026, June 23). Exposome-Wide Association Study. ScholarGate. https://scholargate.app/social-epidemiology/exposome-wide-association-study